Doing a moderate to intense workout for about 262 minutes a week is the sweet spot for protecting your heart — going more than that doesn’t help any more.
See the scientific wording
Moderate-to-vigorous physical activity (MVPA) is associated with a reverse J-shaped relationship with cardiovascular disease risk, where the greatest risk reduction occurs at approximately 262 minutes per week, and no additional benefit is observed beyond this level.
Correlational — new studies may shift this
ObservationalOne moderate-quality study links this claim to the outcome, but causation is not established.
What the research says
1 study reviewedSupporting (1)
Cohort StudyHuman2025
This study found that exercising between about 4 and 4.5 hours a week lowers heart disease risk the most, and doing more than that doesn’t help much more — just like the claim says.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
Doing a moderate to intense workout for about 262 minutes a week is the sweet spot for protecting your heart — going more than that doesn’t help any more.
Evidence from Studies
Supporting (1)
Community contributions welcome
This study found that exercising between about 4 and 4.5 hours a week lowers heart disease risk the most, and doing more than that doesn’t help much more — just like the claim says.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review and Meta-Analysis of Prospective Cohort Studies on MVPA Dose-Response and Cardiovascular Disease Risk in Adults
Includes only prospective cohort studies with objective MVPA measurement (e.g., accelerometers), adjusted for confounders, reporting CVD events over ≥10 years, with subgroup analysis by weekly MVPA dose.
Randomized Trial of Prescribed MVPA Doses (0, 150, 262, 400 min/week) on Cardiovascular Events in Middle-Aged Adults
Randomly assigns 5,000 sedentary adults to one of four MVPA groups (0, 150, 262, 400 min/week) with supervised exercise and objective monitoring; follows for 8–10 years for hard CVD endpoints.
Prospective Cohort Study of MVPA and Cardiovascular Disease Incidence in a National Health Survey Population
Large, nationally representative cohort with annual MVPA assessment via validated questionnaires or accelerometers, CVD outcomes adjudicated by medical records over 15+ years, adjusted for age, sex, BMI, smoking, etc.
Cross-Sectional Analysis of MVPA Levels and Prevalence of Subclinical CVD Markers in a Population-Based Sample
Single-timepoint survey of 10,000 adults measuring self-reported MVPA and objective CVD biomarkers (e.g., echocardiography, blood markers); analyzes non-linear trends.
Case-Control Study Comparing Lifetime MVPA Exposure in Adults With vs. Without First-Time Cardiovascular Events
Recruits 1,000 incident CVD cases and 1,000 matched controls; uses retrospective questionnaires and activity diaries to estimate lifetime MVPA exposure, stratified by weekly dose.